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Epicardially derived cells (EPDCs) delaminate from the primitive epicardium through an epithelial-to-mesenchymal
transformation (EMT). After this transformation, a subpopulation of cells progressively invades myocardial and valvulosep-
tal tissues. The first aim of the study was to determine the tissue-specific distribution of two molecules that are thought to
play a crucial function in the interaction between EPDCs and other cardiac tissues, namely the Wilms’ Tumor transcription
factor (WT1) and retinaldehyde-dehydrogenase2 (RALDH2). This study was performed in normal avian and in quail-to-chick
chimeric embryos. It was found that EPDCs that maintain the expression of WT1 and RALDH2 initially populate the
subepicardial space and subsequently invade the ventricular myocardium. As EPDCs differentiate into the smooth muscle
and endothelial cell lineage of the coronary vessels, the expression of WT1 and RALDH2 becomes downregulated. This
process is accompanied by the upregulation of lineage-specific markers. We also observed EPDCs that continued to express
WT1 (but very little RALDH2) which did not contribute to the formation of the coronary system. A subset of these cells
eventually migrates into the atrioventricular (AV) cushions, at which point they no longer express WT1. The WT1/
RALDH2-negative EPDCs in the AV cushions do, however, express the smooth muscle cell marker caldesmon. The second
aim of this study was to determine the impact of abnormal epicardial growth on cardiac development. Experimental delay
of epicardial growth distorted normal epicardial development, reduced the number of invasive WT1/RALDH2-positive
EPDCs, and provoked anomalies in the coronary vessels, the ventricular myocardium, and the AV cushions. We suggest that
the proper development of ventricular myocardium is dependent on the invasion of undifferentiated, WT1-positive, retinoic
acid-synthesizing EPDCs. Furthermore, we propose that an interaction between EPDCs and endocardial (derived) cells is
imperative for correct development of the AV cushions. © 2002 Elsevier Science (USA)
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The primitive cardiac tube initially consists of two con-
centric layers of cells: an inner endothelial layer, better
known as the endocardium, and an outer layer formed by
primitive myocardial cells (reviewed in Wessels and Mark-
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All rights reserved.wald, 2000). Both layers are separated by an extracellular
matrix-rich, acellular space, commonly referred to as the
cardiac jelly. After completion of cardiac looping, a third
layer of cells appears on the myocardial surface of the heart.
This epithelial layer is known as the epicardium (Viragh
and Challice, 1973). Whereas both the endocardium and
myocardium differentiate from the precardiac mesoderm of
the original heart fields (Tam and Schoenwolf, 1999; Lough
and Sugi, 2000; Wessels and Markwald, 2000), the epicardialTo whom correspondence should be addressed. Fax: (843) 792-
cells derive from an extracardiac source of coelomic origin,0664. E-mail: wesselsa@musc.edu.307
the proepicardium (Viragh and Challice 1981; Viragh et al.,
1993; Ma¨nner et al., 2001).
After the formation of the epicardium (Ho and Shimada,
1978; Komiyama et al., 1987; Hiruma and Hirakow, 1989;
Hirakow, 1992), an epithelial-to-mesenchymal (EMT) trans-
formation of a subset of epicardial cells (epicardial EMT)
results in the generation of epicardially derived cells (EP-
DCs), which initially migrate into the subepicardial space.
In vitro epicardial EMT reportedly can be induced by
several growth factors, including epidermal growth factor
(EGF) and basic fibroblast growth factor (bFGF) (Dettman et
al., 1998; Morabito et al., 2001). Local accumulation of
EPDCs in the subepicardial space of junctional areas of the
heart occurs; these regions include the interventricular
sulcus, the atrioventricular (AV) junction, and conoven-
tricular (CV) grooves.
The developmental fate of EPDCs can be studied by using
several techniques. In particular, the quail-to-chick chi-
mera approach (transplantation of a quail proepicardium
onto a chick host heart) has been proven extremely infor-
mative. This technique allows the immunohistochemical
identification of virtually all (pro)epicardially derived quail
donor cells with a quail-specific antibody (QCPN), while at
the same time characterizing their state of differentiation
by using cell type-specific (e.g., endothelial and smooth
muscle cell) antibodies. The above-mentioned studies have
demonstrated that, after their formation, a subpopulation of
EPDCs migrates into myocardial tissues (specifically the
AV and ventricular myocardium) and differentiates in situ
into interstitial fibroblasts, coronary smooth muscle cells,
and coronary endothelium (Pe´rez-Pomares et al., 1997,
1998; Dettman et al., 1998; Gittenberger-de Groot et al.,
1998; Ma¨nner, 1999). The quail-to-chick chimera studies
have also demonstrated that a subset of EPDCs has the
ability to migrate through the myocardial wall of the
developing heart to finally populate the mesenchymal tis-
sue of the AV endocardial cushions. Interestingly, it appears
that EPDCs do not migrate into the endocardial cushions of
the outflow tract (Ma¨nner, 1999).
In recent years, a series of markers have been described
that might provide more insight into the cell biology of the
epicardial and epicardially derived cell. The novel cell
adhesion molecule bves is expressed in the proepicardium,
epicardium, and EPDCs (Reese and Bader, 1999; Wada et al.,
2001) and seems to play an important role in epicardial
cell–cell interactions. Other factors preferentially ex-
pressed in epicardial cells and of crucial importance for
normal cardiac development are FOG2 (Tevosian et al.,
2000), alpha-4 integrin (Yang et al., 1995; Pinco et al., 2001),
epicardin/capsulin (Hidai et al., 1998; Robb et al., 1998),
and Wilms’ tumor transcription factor (WT1; Moore et al.,
1999).
In this paper, we specifically focus on the tissue distri-
bution of two epicardially expressed molecules that may
play a crucial role in the interaction between EPDCs and
other cardiac tissues, namely WT1 and retinaldehyde-
dehydrogenase2 (RALDH2). In a previous study, we dem-
onstrated strong cardiac expression of WT1 restricted to
the late proepicardial stage (H/H18), the developing epi-
cardium, and presumptive EPDCs in avian embryos (Car-
mona et al., 2001). WT1 expression has also been de-
scribed in the developing epicardium in the mouse
(Moore et al., 1998). The WT1 gene encodes for a zinc-
finger transcription factor reported to be related with
normal cell division and differentiation (Armstrong et al.,
1993). WT1 putative targets seem to be multiple, includ-
ing the genes of some receptors for retinoic acid (RA) and
insulin-like growth factor1 (IGF1), as well as other
growth factor genes like the IGF2 or the platelet-derived
growth factor-A (PDGF-A) (Little et al., 1999). WT1
knockout (k.o.) mice are characterized by underdevelop-
ment of the urogenital system (Kreidberg et al., 1993) and
by an abnormally developed epicardium with greatly
reduced numbers of EPDCs combined with perturbation
of coronary system (Moore et al., 1999). Although WT1 is
only expressed in the epicardium and related cells, the
k.o. embryos eventually die because of severe impair-
ment of myocardial development resulting in pericardial
hemorrhage (Moore et al., 1999).
RALDH2 is a key enzyme in the synthesis of retinoic acid
(McCaffery and Dra¨ger, 1995) and is expressed in primitive
avian (Xavier-Neto et al., 2000) and murine (Moss et al.,
1998) epicardium but not in myocardial or endocardial
cells. The role of retinoic acid (RA), its receptors, and
related molecules in cardiac development is complex and
has not been elucidated completely. In the case of
RALDH2, it has been postulated that its RA synthetic
activity is related to muscular differentiation as RALDH2-
producing mesenchyme invades myogenic populations
(Berggren et al., 2001). Cardiac developmental defects can
be induced by depriving the heart of RA as well as by
exposing the heart to increased levels of RA. Cardiac defects
are also found in the retinoic acid X receptor (RXR)-alpha
k.o. mouse (Gruber et al., 1996). One of the features of the
RXR-alpha k.o. mouse is a characteristic hypoplastic com-
pact (“thin”) myocardial layer (Dyson et al., 1995) that
closely resembles the myocardial phenotype of the WT1-
defective mouse.
All the observations related to the experimental or ge-
netic disruption of epicardial development strongly suggest
that the epicardium and the EPDCs play a very important
role in cardiac development. Indeed, a series of studies show
that experimental and genetic perturbation of epicardial
development leads to severe anomalies in myocardial and
coronary development. (Ma¨nner, 1993; Kwee et al., 1995;
Yang et al., 1995; Moore et al., 1999; Gittenberger-de Groot
et al., 2000). Very little is known, however, about the
cellular and molecular mechanisms involved in the inter-
action between EPDCs and other tissues in the heart during
cardiogenesis.
In this paper, we describe the origin and fate of EPDCs in
normal avian and quail-to-chick chimeric embryos using
RALDH2, WT1, and a panel of “tissue-specific”/
differentiation markers. These markers included cytokera-
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tin (CK), a good marker for early epicardial development
(Vrancken Peeters et al., 1995; Pe´rez-Pomares et al., 1997),
QCPN, a quail-specific antibody, QH1 specific for quail
(hem)angioblasts (Pardanaud et al., 1987), and caldesmon/
smooth muscle alpha-actin as markers for smooth muscle
cells and related cell types (Mikawa and Gourdie, 1996). We
then moved to experimental in ovo models to disrupt
epicardial development (proepicardial ablations and proepi-
cardial block) to analyze in detail how perturbation of
EPDC development interferes with cardiac development.
MATERIALS AND METHODS
The animals used in this study were handled in compliance with
the Guide for the Care and Use of Laboratory animals published by
the U.S. National Institutes of Health (NIH). Chick and quail eggs
were kept in an incubator at 37°C. The avian embryos were staged
according to Hamburger and Hamilton (1951).
Proepicardial Quail/Chick Chimeras
Quail-to-chick proepicardial chimeras were essentially prepared
as previously described (Ma¨nner, 1999) with the following modifi-
cations: Host chick embryos were incubated until stages H/H16–
H/H17. At this point, the eggs were carefully windowed. Using
sharpened tungsten needles, small openings were made through the
vitelline and chorionic membranes to expose the pericardial cavity.
For each embryo, a small piece of the eggshell membrane was cut
with iridectomy scissors and made to fit exactly between the
sinoatrial sulcus and the caudal vitelline veins. Then, stage
H/H16–H/H17 quail embryo donors were excised and perfused
with EBSS (GIBCO). The heart was removed by cutting it through
the outflow tract and the sinoatrial sulcus. The previously prepared
eggshell membrane was introduced through the omphalomesen-
teric vein of the quail embryo and pushed until it reached the
cardiac lumen, so that the sinus venosus formed a cuff around the
membrane, holding the donor proepicardium on its surface (see Fig.
2B). The membrane carrying the quail (donor) proepicardium was
inserted facing the ventricular heart surface. After the operation,
the eggs were sealed with Scotch tape and reincubated to obtain
H/H25–H/H26 (2 chimeras, 96–108 h of incubation), H/H28–H/
H29 (4 chimeras, 132–144 h of incubation), or H/H32 (2 chimeras,
180 h of incubation). Four chimeras were fixed in modified Am-
sterdam’s Fixative (methanol:acetone:water  2:2:1), dehydrated in
a graded series of ethanol, cleared in toluene, carefully oriented,
and embedded in paraffin (Paraplast Plus, OXFORD Labware,
St. Louis). Finally, 5-m serial sections were mounted on micro-
scope slides (Superfrost/Plus, Fisherbrand, Fisher Scientific, Pitts-
burgh, PA). For cryostat sections, four chimeras were processed as
described for WT1 immunohistochemistry.
FIG. 1. Expression pattern of CK, RALDH2, and WT1 in the developing avian heart. (A, D, G, J) The specific WT1 expression in epicardial
and EPDCs throughout stages H/H19–H/H30. (A) Adhesion of proepicardial villi (arrow) and formation of the epicardial layer (arrowheads)
in a H/H19 chick embryo. Note that all the cells express WT1. The coelomic epithelium (double arrowhead) acts as positive control. Bar,
30 m. (D) A detail of the atrioventricular groove of a H/H26 chick embryo. WT1 expression shows a gradient from the outer areas (arrow,
strong expression) to the inner areas (asterisk, weak expression) of the groove. Note the presence of WT1-positive EPDCs in the ventricular
myocardium (arrowheads) but not in the atrial myocardium. Bar, 30 m. (G) The first WT1-positive cells appearing in the ventricular wall
of an H/H26 chick embryo are pointed with arrowheads. Pericardium is also WT1-positive. Bar, 30 m. (J) The ventricular compact
myocardium of an H/H30 chick embryo is presented. The arrowheads indicate isolated WT1-positive cells and arrows point to groups of
cells. Note the absence of WT1-positive cells in the ventricular trabeculated myocardium. Bar, 30 m. (B, E, H, K) The RALDH2 expression
in epicardial and EPDCs throughout stages H/H19–H/H29. (B) First stages of epicardial development (H/H19 chick embryo). The
proepicardial mass is still prominent and strongly expresses RALDH2 (arrow). Attachment of proepicardial cells has generated an epicardial
monolayer around the AV region and some close areas in the atrium and ventricle (arrowheads). Subepicardial mesenchymal cells are
almost absent from the heart at this point. Bar, 80 m. (E) The AV region of a stage H/H26 chick embryo is shown. RALDH2 expression
is strong in the EPDCs closer to the epicardium (arrow), while cells in contact with the myocardium have a lower level of WT1 expression
(asterisk). Bar, 20 m. (H) A magnification of the compact ventricular myocardium of a stage H/H26 chick embryo shows the presence of
RALDH2-positive cells into the subepicardial space (arrows) and myocardial layers (arrowheads). Bar, 40 m. (K) A detail of the ventricular
myocardium of a stage H/H29 chick embryo. Epicardial epithelium expresses RALDH2. The expression in the subepicardial mesenchyme
is heterogeneous; some cells strongly express RALDH2 but others do not. Some RALDH2-positive cells can be found infiltrated in the
myocardial layers (arrowheads). Bar, 40 m. (C, F, I, L) The CK expression in epicardial and EPDCs throughout H/H19–H/H29 stages of
avian development. (C) The formation of epicardium (EP) around the AV myocardium is shown as it develops from proepicardial villi (PV)
in a stage H/H19 chick embryo. Both epicardium and proepicardial tissue are CK-positive. The few mesenchymal cells that start to populate
the subepicardial matrix are also CK-positive (arrowheads). Bar, 70 m. In (F), the AV groove of a stage H/H26 chick embryo is presented.
Epicardium (EP) and most subepicardial cells (arrowheads) are CK-positive all through the subepicardium. Some CK-expressing cells can be
seen in the outer layers of the atrioventricular myocardium of a stage H/H26 chick embryo (arrow). Bar, 13 m. (I) The CK expression in
the embryonic epicardium of a stage H/H26 chick embryo. Note that some CK-positive cells appear in the ventricular compact myocardial
layer (arrowheads). Bar, 20 m. In (L), an image of the ventricular wall of a stage H/H29 chick embryo is shown. All the epicardial
mesothelium is CK-positive. Some of the subepicardial mesenchymal cells do express CK, whereas this expression is weak or absent in
other subepicardial cells. No CK-positive cells are seen within the ventricular myocardium. Bar, 20 m. A, atrium; AM, atrial myocardium;
AVC, atrioventricular canal; AVG, atrioventricular groove; AVM, atrioventricular myocardium; CVM, compact ventricular myocardium;
EP, epicardium; EN, endocardium; LI, liver; PE, pericardium; PV, proepicardial villi; SE, subepicardium; SV, sinus venosus; VM, ventricular
myocardium; TVM, trabeculated ventricular myocardium.
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FIG. 2. Quail-to-chick chimeras. Cartoons in (A–C) depict the basic steps of the quail-to-chick proepicardial transplantation. As shown,
the entire quail proepicardium from stage H/H16–H/H17 is transplanted together with a piece of the sinus venosus (all in green) by using
a piece of eggshell membrane as a carrier (in blue). In (B), the specific location of the explant is shown. (C) The chimeric results. All the
cartoons are illustrated with laser confocal microscopy pictures. Quail nuclei (QCPN-positive) appear as green dots. (A) A QCPN-stained
H/H18 quail proepicardium; all the nuclei, including those of the mesothelial cells (arrows), and associated mesenchyme (arrowheads)
appear labeled as green dots. Bar, 12 m. In (B), the myocardially attached explant (E) is shown in an H/H29 chimera. Note the EPDCs in
the epicardium (EP), subepicardium (arrows), myocardium (double arrowheads), and endocardium of the trabeculae (arrowheads). Bar, 170
m. The detail in (B) presents the tissue bridge that joins the explant with the myocardial surface in the same specimen (arrowheads). The
arrows indicate the presence of QCPN-positive cells in the subepicardial space. Bar, 35 m. (C) The formation of epicardial and
subepicardial tissue from the donor (H/H29 chimera). Vascular structures are indicated with asterisks. Bar, 20 m. In (C), EPDCs in the
developing AV cushions of an H/H36 chimera are shown. EPDCs are pointed with arrowheads. Bar, 20 m. A, atrium; CM, cushion
mesenchyme; E, explant; EN, endocardium; EP, epicardium; MYO, myocardium; O, outflow tract; SE, subepicardium; and V, ventricle.
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Immunohistochemistry
The normal expression pattern of WT1 was studied in a series of
Japanese quail embryos (Coturnix coturnix japonica) ranging from
stages H/H18 to H/H30 and in chick embryos (Gallus gallus) of
stages H/H18–H/H31. For WT1 immunohistochemistry, the em-
bryos were excised and cryoprotected in 10, 20, and 30% sucrose
solutions in TPBS (Tris phosphate-buffered saline), where they
were kept at 4°C until they sunk. Then, the embryos were
embedded in OCT-embedding media (TissueTek) and snap-frozen
in liquid nitrogen-cooled isopentane. Sections (10–14 m) were
obtained in a cryostat, collected on poly-L-lysine-coated slides, and
fixed for 10 min in 1:1 methanol/acetone solution at 20°C.
Sections were rehydrated in TPBS and nonspecific binding sites
were saturated for 30 min with 4% normal goat serum, 1% bovine
serum albumin, and 0.1% Triton X-100 in PBS (GBT). The slides
were incubated overnight at 4°C by using a polyclonal anti-human
WT1 (Santa Cruz, C-19) antibody diluted 1:50 in PBS (0.04 mg
IgG/ml) followed by an incubation (1 h, room temperature) in a
secondary biotin-conjugated anti-rabbit goat IgG (Sigma) diluted
1:100 in GBT. Then, the sections were incubated for 1 h in
extravidin–peroxidase complex (Sigma) diluted 1:150 in TPBS,
washed in TPBS, and the peroxidase activity developed with Sigma
Fast 3,3-diaminobenzidine tablets (DAB) according to the suppli-
er’s instructions. Cytokeratin (Dako Z0622; diluted 1:100 in GBT)
or RALDH2 (gift from Drs. P. McCaffery and U. Dra¨ger; diluted
1:5000 in GBT) expressions were studied in 10-m paraffin sections
following the same protocol. Caldesmon (gift from Dr. Gourdie)
and alpha-smooth muscle cell actin (Sigma A-2547) stainings in
normal control (nonchimeric) or chimeric embryos were performed
in both cryostat or paraffin sections following the immunofluores-
cence protocol described below.
For double antigen colocalization, cryostat (QCPN/WT1;
QCPN/RALDH2) or paraffin sections (QCPN/cytokeratin; QCPN/
RALDH2; QCPN/caldesmon; QH1/caldesmon; vimentin/RALDH2;
vimentin/cytokeratin: MF20/cytokeratin) of the proepicardial chi-
meras were used. Cryostat sections were obtained and processed as
described for WT1. The first labeling step was an overnight
incubation at room temperature of the sections in the monoclonal
antibodies (QCPN undiluted, QH1 diluted 1:200 in GBT, anti-
vimentin 1:75 in GBT, and MF20 1:20 in PBS; all obtained from the
Developmental Studies Hybridoma Bank). After three washes in
PBS, monoclonal antibody labeling was detected by using sheep-
anti-mouse biotinylated antibody (Amersham RPN-1001; 1:100 in
PBS, 2 h, room temperature), washed again (3  10 min, PBS), and
incubated in extravidin–FITC (Amersham RPN-1232). After wash-
ing in PBS (3  10 min), the sections were then incubated overnight
at room temperature in polyclonal antibodies (anti-WT1 1:50 in
PBS, anti-cytokeratin 1:100 in PBS, anti-caldesmon 1:100 in PBS,
and anti RALDH2 1:5000 in PBS). Then, 3  10 min PBS washes
were followed by an incubation (2 h, room temperature) with a
goat-anti-rabbit antibody (AlexaFluor-568, Molecular Probes). After
extensive washes, the sections were mounted in 1:1 PBS/glycerol
solution and analyzed by using a BioRad MRC 1024 laser scanning
confocal microscope. In some of the figures, the caldesmon expres-
sion (goat-anti-rabbit Alexa Red 568 detected with the 605-nm
wave-length filter on the confocal microscope) is shown in purple
to improve signal/noise ratio.
Proepicardial Blocks and Proepicardial Ablations
Proepicardial block. To block attachment of the proepicar-
dium to the heart, the eggshell membrane technique (Ma¨nner,
1993) was used. Chick embryos were incubated until stages
H/H16–H/H17. Openings in the vitelline and chorionic mem-
branes were created by using tungsten needles. A small piece of
eggshell membrane was inserted between the sinoatrial sulcus and
the caudal vitellin veins, thus temporarily preventing the heart to
be covered by epicardium.
Proepicardial ablation. The ablation was performed by excis-
ing the proepicardium of chick embryos at stages H/H16–H/H17
using fine dissecting tungsten needles.
After the surgical procedure, blocked or ablated embryos were
reincubated for 96–120 h (resulting in H/H25–H/H27 embryos),
132–144 h (resulting in H/H28–H/H29 embryos), or 180–216 h
(resulting in H/H32–H/H35 embryos). The embryos were fixed in
modified Amsterdam’s fixative, embedded in Paraplast Plus, sec-
tioned on a microtome (5 m), and stained with hematoxylin–
eosin or processed for immunohistochemical staining. In addition,
some of the blocked or ablated embryos used for WT1 character-
ization were frozen in liquid nitrogen-cooled isopentane, sectioned
in a cryostat, and immunostained for WT1.
RESULTS
Spatiotemporal Expression Patterns of WT1,
Cytokeratin, and RALDH2 (Fig. 1)
Wilms’ Tumor Expression
In the stages that precede epicardial development, WT1
expression is restricted to the proepicardium and to the
coelomic epithelium that constitutes the developing pari-
etal pericardium (data not shown; see also Carmona et al.,
2001). At the end of stage H/H17, the proepicardium at-
taches to the heart and spreads over the myocardium,
forming the epicardial layer which strongly expresses WT1.
Around stage H/H18, the first mesenchymal cells can be
seen in the subepicardial space of the areas covered by
epicardium. These cells first appear in the AV groove and at
the end of stage H/H19 (Fig. 1A) in the CV groove and
ventricular region. Virtually all early subepicardial mesen-
chymal cells (EPDCs) are WT1-positive. As epicardial de-
velopment proceeds, WT1 expression is found in the epi-
cardium that covers the cardiac chambers. In stages
H/H20–H/H26, the number of mesenchymal cells increases
in the subepicardial space of the AV groove, CV groove, and
the subepicardium of the ventricles (Figs. 1D and 1G). In
these junctional regions, a gradient in WT1 expression is
evident. Within the AV subepicardium, the EPDCs closer to
the epicardium express more WT1 than those located closer
to the myocardium (Fig. 1D). At stages H/H25–H/H26, the
first WT1-positive cells can be seen invading the ventricu-
lar myocardium. No WT1-positive mesenchymal cells can
be detected in the atrium (Fig. 1D). WT1 continues to be
expressed in the epicardium and subepicardial cells during
later stages of development (H/H27–H/H33). At these
stages, the number of WT1-positive intramyocardial cells
within the ventricular myocardium increases significantly.
Most of the WT1-positive cells are found in the outer
(compact) myocardial layer, whereas only a few WT1-
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positive cells can be found in the inner trabecular layers of
the myocardium (Fig. 1J).
RALDH2 and CK Expression
The expression patterns obtained with the anti-CK and
the anti-RALDH2 antibodies are similar. During early
stages of epicardial development (H/H17–H/H19), the pro-
epicardium and the developing epicardial layer strongly
express RALDH2 and CK (Figs. 1B and 1C). The subepicar-
dial mesenchyme of the ventricles is scarce and seems to be
organized as a single cell layer. Subepicardial mesenchymal
cells are absent from the atrium. During stages H/H20–H/
H26, both RALDH2 and CK are expressed in the subepicar-
dial mesenchymal population. RALDH2 and CK display the
same characteristic gradient of expression described for
WT1. The difference in expression between the outer and
inner subepicardial layers is higher for RALDH2 than for
CK (Figs. 1E and 1F). At the end of stage H/H26, a number
of RALDH2/CK-positive cells can be seen in the compact
myocardial layer of the ventricles (Fig. 1H and 1I), but not in
the atrial or outflow tract myocardium. At stages H/H27–
H/H33, the RALDH2 and CK expression in the epicardium
is strong, but in most subepicardial cells and mesenchymal
cells infiltrating the myocardial layers, the level of expres-
sion is weak or undetectable (Figs. 1K and 1L).
Quail-Chick Chimeras (Fig. 2)
Quail-chick chimeras were prepared by transplanting
proepicardium from quail origin (Figs. 2A and 2A) into a
chick host by using a piece of eggshell membrane (Fig. 2B).
This procedure not only allows the quail epicardium to
populate the chick heart, but it also prevents the attach-
ment of the chick proepicardium to the heart (Fig. 2B).
The epicardium formed on the myocardial surface of the
chick hosts in the quail-chick chimeras was QCPN-
positive, indicating a donor (quail) origin (Figs. 2B and 2B).
The subepicardial mesenchymal cells were also QCPN-
positive (Figs. 2B, 2B, and 2C). A subset of these QCPN-
positive cells contribute to the formation of subepicardial
coronary vessels (Fig. 2C). Around stages H/H25–H/H26,
QCPN-positive cells start to migrate into the ventricular
wall. From stages H/H28–H/H29 onward, QCPN-positive
cells are found throughout the ventricular wall, some quail
cells even being observed in the endocardial lining of the
developing ventricular trabeculae (Fig. 2B). In the AV
junction, QCPN-positive cells start to invade the myocar-
dium at stages H/H29–H/H30, at which stage sporadic
QCPN-positive cells are also observed in the endocardial
cushions. A considerable number of QCPN-positive cells
are detected in the cushions around H/H31–H/H32 (Fig.
2C). It is important to note that QCPN-expressing immi-
grating cells were never observed in the atrial myocardium
(Fig. 2B) or the outflow tract (data not shown).
Molecular Phenotype of the Epicardial-Derived
Cells in the Quail-Chick Chimera (Figs. 3 and 4)
QCPN-positive (i.e., quail-derived) epicardial and subepi-
cardial cells show the same molecular phenotype as de-
scribed for the normal epicardium and its derivatives (see
Fig. 1). Thus, CK (Figs. 3A and 3B), RALDH2 (Figs. 3C and
3D), and WT1 (Figs. 3E and 3F) are expressed in the
epicardium and virtually all subepicardial cells. CK and
RALDH2 are also expressed in the cells invading the
amyocardium, but this expression is lost progressively as
the cells continue to migrate. The WT1 expression can still
be observed in QCPN-positive cells that have migrated deep
into the compact myocardium and the trabeculae (Figs. 3E
and 3F). However, WT1/QCPN-positive cells are not found
in the endocardial cushions (not shown).
A subset of epicardial and subepicardial QCPN-positive
cells in the chimeras also express caldesmon. These cells
are specifically found in the AV and CV grooves related to
the developing media of the subepicardial coronary arteries.
(Figs. 4A and 4B). Interestingly, some of the QCPN-positive
cells found in the AV endocardial cushions express caldes-
mon as well (Figs. 4D–4F). The majority of the caldesmon-
expressing cells are located in the subendothelial layer of
the cushions, although some weakly caldesmon-expressing
QCPN-positive cells are found in the core of the cushions.
FIG. 3. Proepicardial cell tracing in quail-to-chick chimeras. (A) The AV groove of a stage H/H32 chimera. EPDCs are labeled with the
quail-specific nuclear marker QCPN (green dots) and an anti-cytokeratin antibody (red). Bar, 65 m. (B) A detail of a cluster of EPDCs (arrow
in A). Some EPDCs in the myocardium retain their cytokeratin immunoreactivity in the cytoplasm (arrowheads). Bar, 33 m. In (C), the
RALDH2 expression (red) in donor-derived tissues (green nuclei) of a stage H/H29 chimera is shown. The epicardial epithelium, derived
from the donor, is completely RALDH2-positive. In some areas of the ventricle, EPDCs (QCPN-positive nuclei) that express RALDH2
(cytoplasmic expression) can be seen within the myocardial layers (arrowheads). Bar, 65 m. (D) The AV sulcus of a stage H/H29 chimera.
The RALDH2 signal is partially lost and the majority of the infiltrated EPDCs are RALDH2-negative (arrowheads). However, some cells are
still faintly stained by the RALDH2 antibody (arrows). Bar, 65 m. (E, F) Details of WT1 expression in a stage H/H32 chimera. Epicardial
and subepicardial populations coexpress QCPN (green) and WT1 (red). Both are nuclear markers, so nuclei of the EPDCs appear as yellow
dots in the epicardium, subepicardium, and myocardium. Part of the invasive EPDC population invades the myocardium as rows of
QCPN/WT1-positive cells (arrow in F). The pericardial tissue, which is strongly expressing WT1, is QCPN-negative and not derived from
quail donor tissue, (red dots). Bars, 33 m. AM, atrial myocardium; AVM, atrioventricular myocardium; EN, endocardium; EP, epicardium;
LI, liver; MYO, myocardium; PE, pericardium; SE, subepicardium; VM, ventricular myocardium.
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FIG. 4. EPDCs differentiate into a smooth muscle cell(-like) phenotype. In (A) and (B), the formation of coronary vessels from the quail
proepicardial explant is shown in a stage H/H36 chimera. In (A), QCPN-labeled EPDCs (green nuclei) are found in the subepicardium and
myocardium (arrowheads), and in endothelium (double arrowhead) and media of the coronary vessels. The smooth muscle cells express the
smooth muscle antigen caldesmon (red staining, arrows). Bar, 33 m. In (B), another detail from the same chimera is presented.
Quail-derived vascular cells have been stained with the QH1 antibody (green), while smooth muscle cells appear in red (caldesmon
expression, arrow). Note the presence of vessels of small caliber that have not developed a muscular wall (QH1 red labeling, arrowheads).
Bar, 33 m. The image in (C) shows smooth muscle cell -actin expression in the AV cushions of an H/H29 chimera. Arrows indicate
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The caldesmon expression pattern coincides with the ex-
pression pattern of smooth muscle alpha-actin (Fig. 4C).
Proepicardial Block and Proepicardial Ablation
(Figs. 5 and 6)
Proepicardial block experiments result in different phe-
notypes as compared with those obtained by a direct pro-
epicardial ablation.
The proepicardial block experiments generally do not
prevent the formation of the epicardium, but rather cause a
general delay in the process. This is a result of the fact that
the proepicardium will often grow around the blocking
eggshell membrane to reach the myocardial surface of the
heart. Proepicardial ablation prevents epicardial develop-
ment for 12–24 h; after that period, a compensatory me-
sothelial proliferation often develops in the original proepi-
cardial location and initiates the development of an
epicardial-like tissue.
The cardiac phenotype observed after blocking experi-
ments ranges from almost normal to severely abnormal
(Figs. 5A and 5B). The abnormalities, most of them typically
observed from stages H/H27–H/H28 onward, include local-
ized or severe reduction of the thickness of the compact
ventricular myocardium (Figs. 5A–5D), small gaps in myo-
cardial continuity (Fig. 5E), and occasionally pouch-like
myocardial interruptions (Fig. 5F) where the ventricular
lumen is contiguous with the subepicardial space/
subepicardial vascular structures (Fig. 5F). These small and
large disruptions in the myocardial continuity sometimes
result in subepicardial bleeding (hemorrhage) (Figs. 5D–5F).
The malformations also include abnormalities of the coro-
nary system (see Discussion). Another characteristic fea-
ture of the proepicardial blocked embryos was valvuloseptal
dysmorphogenesis. This was particularly prominent in the
older embryos examined (H/H35). The AV cushions of these
experimental embryos were much larger than those of the
controls (Fig. 5B, compare with Fig. 5A).
Compared with the blocked embryos, the cardiac abnor-
malities seen in proepicardial ablated embryos (Figs. 6B and
6C) are more severe and are present at earlier stages of
development. These abnormalities frequently include wide
myocardial pouch-like discontinuities, similar to those that
were occasionally seen in the blocked specimens (see above)
and which form endocardial–subepicardial connections
(Fig. 6C), and occasionally malformations of the ventricular
septum (Fig. 6B). In addition, the formation of AV endocar-
dial cushion tissue is also abnormal. Compared with nor-
mals (Fig. 6A), the AV cushions in ablated embryos extend
deeper into the ventricular segments (Fig. 6B). It is impor-
tant to note that most of the ablated embryos died around
stage H/H31, i.e., the stage that the coronary subepicardial
plexus connects to the circulation. A few ablated embryos,
however, survived up to stage H/H34–H/H35.
Molecular Characterization of the Phenotype of
Proepicardial Ablated (Fig. 7) and Blocked
Embryos (Fig. 8)
As mentioned above, proepicardial ablation is followed
by the generation of a compensatory (pro)epicardial-like
tissue (Fig. 7A), which eventually migrates over the myo-
cardial surface of the heart. This migration is delayed (i.e.,
the epicardial-like tissue arrives later) and incomplete (i.e.,
some areas do not become covered at all). In addition, in the
limited subepicardial space that is formed in those areas
that are covered, only very few subepicardial cells can be
found. The myocardial wall in the ablated embryos that is
not covered by the epicardial-like tissue is considerably
thinner than the myocardial wall in the areas covered with
this tissue (Fig. 7B). The walls in these specimens fre-
quently show myocardial indentations and/or interruptions
(Fig. 7C).
At stage H/H26–H/H27, the pouch-like structures that
bulge out from the ventricular lumen protrude into the
subepicardium for 100–200 m. The pouches are lined with
vimentin-positive endothelial cells. These cells, however,
do not express epicardial markers such as CK and RALDH2.
These epicardial markers, however, are expressed in the
subepicardial tissues surrounding the pouches (Figs. 7D and
7E). In the embryos that survived up to stage H/H34–H/
H35, the subepicardial tissues adjacent to the endothelial
lining of the pouches undergo compaction to form a multi-
layered wall. Within this wall, the cell layers closest to the
endothelium express caldesmon (Fig. 7F).
The AV cushions in experimental embryos are mal-
formed (see Figs. 5 and 6). The expression of SMA in the
endocardial AV cushions of control and proepicardial ab-
lated specimen at H/H31 is shown in Figs. 7G and 7H. No
significant difference in the level of SMA expression was
observed.
In the blocking experiments, scarce and discontinuous
epicardium was found. The flattened epicardium covered a
thin subepicardial space in which only a few CK-positive
subendocardial areas of strong expression. Bar, 65 m. (D–F) The presence of donor-derived EPDCs in the AV cushions of the same chimera
illustrated in (C). EPDCs appear as green dots (QCPN nuclear staining); some of these cells coexpress the smooth muscle lineage-related
marker caldesmon (purple). (D) Some of these EPDCs are caldesmon-positive (arrows) while others, located in the core of the cushions, are
caldesmon-negative (arrowheads). Bar, 65 m. (E) The tendency of the EPDCs to accumulate in the subendothelial layers of the AV cushions
(arrowheads), where their caldesmon expression seems to be stronger. Bar, 22 m. In (F), EPDCs migrating into the cushions from the
myocardium are shown. Arrowheads point to caldesmon-negative EPDCs, while the arrow indicates the presence of caldesmon expressing
EPDCs. Bar, 33 m. B, blood; CM, cushion mesenchyme; EN, endocardium; EP, epicardium; MYO, myocardium; SE, subepicardium.
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and RALDH2-positive mesenchymal cells were seen. This
abnormal epicardium/subepicardium usually covered a
“thinned” myocardial area (Figs. 8B–8D). The number of
intramyocardial RALDH2- and WT1-positive cells in the
experimental embryos was also reduced when compared
with controls (Figs. 8A–8D).
DISCUSSION
There is a growing body of evidence that the epicardium
is of great importance for general cardiac development. As
already indicated, experimental manipulation of epicardial
growth (i.e., microsurgery) as well as genetic perturbation
(i.e., knock-out technology) of molecules involved in epi-
cardial cell behavior (e.g., migration, differentiation) have
been reported to disrupt normal development of the heart,
resulting in coronary and myocardial dysmorphogenesis
(Dyson et al., 1995; Kwee et al., 1995; Yang et al., 1995;
Moore et al., 1999; Wu et al., 1999; Gittenberger-de Groot
et al., 2000; Tevosian et al., 2000) and general cardiac
defects involving endocardial cushion tissues and septal
structures (Gittenberger-de Groot et al., 2000; Pe´rez-
Pomares et al., 2001). Most of the knock-out mice die in
utero around ED12–ED13 due to a severe pericardial bleed-
ing and/or cardiac failure caused by thinning of the myo-
cardial wall. Thus, interference with epicardial develop-
ment leads to abnormalities in the formation of superficial
and internal cardiac structures.
The epicardial epithelium only covers the outer surface of
the heart. Initially, it was difficult to understand how
defective epicardial development could generate such a
wide spectrum of cardiac malformations. Recent studies,
however, have shown that the epicardium generates a
population of epicardially derived cells (EPDCs) that in-
vades the heart tissues in a well-defined spatiotemporal
manner, reaching the subepicardial, myocardial and valvu-
loseptal tissues (Pe´rez-Pomares et al., 1997, 1998, 2001;
Dettman et al., 1998; Gittenberger-de Groot et al., 1998;
Ma¨nner, 1999). It has been established that EPDCs differ-
entiate into coronary smooth muscle cells, cardiac fibro-
blasts, and coronary endothelium (Mikawa and Fischman,
1992; Pe´rez-Pomares et al., 1997, 1998; Dettman et al.,
1998; Gittenberger-de Groot et al., 1998; Ma¨nner, 1999).
Very little information was available about the invasive
population of EPDCs in terms of their timing of migration,
range of distribution, and expression of epicardial markers.
In this study, we show the normal distribution of EPDCs
combining a cell-tracing system (quail-to-chick chimeras)
with immunohistochemical molecular characterization us-
ing epicardial and differentiation markers.
EPDCs Invasion of Developing Cardiac Tissues
Our findings show that a population of EPDCs invades
the subepicardial space as well as the ventricular myocar-
dium, the AV myocardium, and the AV endocardial cush-
ions approximately between the stages H/H28–H/H29. The
epicardial epithelium expresses the transcription factor
WT1 and the RA-synthesizing enzyme RALDH2. The sub-
epicardial mesenchymal EPDCs also express both markers.
However, as soon as they migrate into the myocardium, a
process that starts around H/H26, RALDH2 expression is
reduced significantly. The level of expression of WT1 in the
EPDCs then gradually decreases as the cells invade deeper
into the myocardial wall. Thus, the EPDCs found in the AV
endocardial cushions, many of which express caldesmon,
do not express RALDH2 or WT1. In addition, the terminally
differentiated coronary endothelium of EPDC origin (sub-
epicardial as well as intramyocardial), which is character-
ized by the expression of the endothelial specific marker
QH1 (in quail), generally does not express WT1 or
RALDH2. Therefore, the loss of expression of WT1 and
RALDH2 is related to the organization of EPDCs in recog-
nizable structures and the upregulation of molecular mark-
ers of cell lineage-specific differentiation. When we delay
epicardial development, a decrease in the overall number of
EPDCs, and hence also the number of WT1/RALDH2-
positive cells, is observed. This reduction in the number of
cells correlates with malformations of the structures in
which they are normally found. These malformations in-
clude the “thin myocardial syndrome,” abnormal coronary
vessels, and dysmorphic AV cushions. This spectrum of
malformations closely resembles that seen in mice defi-
cient for genes involved in epicardial development (Dyson
et al., 1995; Kwee et al., 1995; Yang et al., 1995; Moore et
al., 1999; Wu et al., 1999; Tevosian et al., 2000).
EPDCs–Myocardial Interaction: A Possible Role for
WT1 and RALDH2 in the Formation of the
Compact Layer of the Myocardial Wall
The invasion of the ventricular myocardium by EPDCs
(stages H/H25–H/H26) coincides with the onset of the
myocardial thickening that leads to the generation of the
compact layer of the ventricular wall. As mentioned above,
at this point, the EPDCs are expressing WT1 and RALDH2.
There is reason to believe that this expression is related to
a specific role for EPDCs in myocardial development. WT1
encodes a zinc-finger transcription factor (Call et al., 1990;
Gessler et al., 1990) which is involved in a large number of
normal functions for cell proliferation, differentiation, and
survival (Armstrong et al., 1993). However, the precise
function of WT1 in normal vertebrate development is not
yet established. It is interesting to note that, in the WT1
k.o. mouse, all the organs that normally harbor an invasive
population of WT1-positive cells (i.e., kidneys, gonads,
adrenals, spleen, cardiac ventricle) either are absent or are
abnormally developed (Moore et al., 1998, 1999). It is
important to emphasize that the ventricular phenotype of
the WT1 k.o. mouse is virtually identical to that of the
VCAM1 k.o. and alpha-4-integrin k.o. mouse, mice that
lack a normal epicardium. Embryos of these three k.o.
models die due to cardiac failure likely caused by ventric-
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FIG. 5. Proepicardial blocks. (A, C) The normal (control) phenotype of a stage H/H35 chick embryo. (B, D–F) An experimental chick embryo at stage
H/H35. In (A) and (B), transverse sections at the level of the AV valves are shown Bar, 700 m. (B) Abnormal ventricular morphology in the ablated
embryo [cf. the size of the left AV (asterisk) and the right AV valves (arrow) in A and B]. The AV valves in the experimental embryo are dysplastic and
the interventricular septum (IVS) looks underdeveloped and poorly compacted. The arrowheads indicate the presence of abnormal trabeculation (cf. A)
Bar, 700 m. In (C), a detail of the compact myocardial layer of the right ventricle in a control embryo is shown. The thickness of the compact
myocardium is indicated by the double-headed arrow. Bar, 25 m. In (D), the myocardium of an experimental embryo is shown at the same
magnification. The double-headed arrows indicate the reduced thickness of the compact myocardium, around one-fifth of the one in the control. Bar,
25 m. In (E), a higher magnification of the myocardium of a proepicardially blocked embryo is presented. The arrow points to a myocardial
discontinuity in the thin compact layer. Blood accumulates in the subepicardial area as indicated by arrowheads. Bar, 50 m. In (F), a pouch-like
structure is shown. The lumen of the pouch is connected with the endocardium (asterisk) and its wall is formed by numerous cells that present a smooth
muscle-like phenotype (arrowheads). Accumulation of blood in the subepicardium is indicated by an arrow. Developing subepicardial vessels are often
found in relation with the pouches (double arrowhead). Bar, 100 m. EP, epicardium; IVS, interventricular septum; LA, left atrium; LV, left ventricle;
MYO, myocardium; PE, pericardium; RV, right ventricle; RA, right atrium; SE, subepicardium.
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ular myocardial hypoplasia around ED13 (Kwee et al., 1995;
Yang et al., 1995; Moore et al., 1999). At this developmental
stage, the coronary system is not yet functional (i.e., not
connected to the general systemic circulation). This implies
that myocardial hypoplasia can not be a direct result of
reduced blood supply from defective coronary arteries.
Taken together, these observations strongly suggest that
the observed myocardial phenotype is caused by abnormal
epicardial development. As discussed above, RALDH2 and
WT1 are expressed in mouse and avian epicardial and
epicardially derived cells. Reducing/abolishing the expres-
sion of WT1 within the primitive myocardial wall, either by
genetic means (WT1 k.o.) or by reducing the number of cells
that express WT1 in the wall (i.e., experimental perturba-
tion of epicardial development), leads to basically the same
cardiac phenotype. The most characteristic feature in this
respect is the thin myocardial wall. Therefore, we conclude
that WT1 expressed by the intramyocardial EPDCs plays a
crucial role in the formation of the thick compact layer of
the ventricular myocardial wall. In this respect, it is inter-
esting to note that during normal development the myocar-
dial layer of the atrium, that remains thin through devel-
opment, does not get invaded by EPDCs.
WT1-positive epicardial and epicardially derived cells
also express the RA-synthesizing enzyme RALDH2. It is
interesting to note that in humans the WT1 transcription
factor downregulates the RAR-alpha gene (Goodyer et al.,
1995) and that the phenotype of the WT1 k.o. mouse closely
resembles that of the RA-depleted (Wilson et al., 1953) and
RXR-alpha k.o. mice (Sucov et al., 1994). Depletion of RA
from the diet is known to severely disturb heart develop-
ment, causing hypoplasia of the ventricles (“thin myocar-
dium”), a phenotype that is also seen in RXR-alpha-
defective mice. Furthermore, ventricular expression of the
myosin light chain 2a (MLC-2a) gene is abnormally persis-
tent in RXR-alpha-deficient embryos. This fact can be
considered both as retardation in ventricular maturation or
as misspecification of the ventricle into an atrial fate
(Dyson et al., 1995). However, other authors have suggested
that, in the absence of proper retinoid signaling, cells might
precociously reach a state of terminal differentiation (Kast-
ner et al., 1994, 1997).
Proepicardial block results in a decreased amount of
WT1-positive, RALDH2-positive intramyocardial EPDCs,
and myocardial abnormalities, including areas of thin com-
pact myocardium, gaps in the myocardial layers, and dys-
morphic AV valvuloseptal tissues. Myocardial defects were
commonly seen in areas that would normally be covered by
epicardium during the first hours of epicardial development
(i.e., in the inner curvature AV, CV, and ventricular areas).
Thus, it is likely that the abnormal myocardial develop-
ment is directly related to the reduction of the numbers of
intramyocardial EPDCs in experimental embryos. A pos-
sible role for epicardial cells in the regulation of cardiomy-
FIG. 6. Proepicardial ablations. (A) An H&E-stained section of a stage H/H31 normal embryo with well-formed ventricles and
interventricular septum (asterisk). The arrows indicate normally developed ventricular epicardium. (B) A section of a stage H/H31 ablated
embryo at a comparable level. The experimental heart is smaller and the amount of subepicardial mesenchyme is greatly reduced (arrows).
The interventricular septum is absent (asterisk) and the valvuloseptal tissue is abnormally extended into the ventricle (arrowheads). Note
that pericardium has been removed. Bars, 700 m. In (C), a magnification of a pouch-like structure protruding into the subepicardial space
of the right ventricle in a stage H/H35 ablated embryo is shown. The pouch consists of an endocardially lined lumen (asterisk) surrounded
by densely packed layers of cells (arrowheads). Bar, 100 m. EP, epicardium; LV, left ventricle; MYO, myocardium; PE, pericardium; RV,
right ventricle; SE, subepicardium.
FIG. 7. Molecular characterization of the phenotype of proepicardial ablated embryos. (A) A cytokeratin staining (red) of a stage H/H27
ablated chick embryo. The region shown in this confocal plane corresponds to the original location of the proepicardium (asterisk). The
arrows indicate the accumulation of mesenchymal coelomic tissue around the area; the arrowheads point to the flattened epicardium
formed over the ventricular myocardium. Bar, 133 m. In (B), the delayed formation of the epicardium in a stage H/H27 ablated chick
embryo is shown. The myocardium has been counterstained with the myosin-specific MF20 antibody (green) and the epicardial cytokeratin
expression appears in red. Note the boundary between epicardially covered and bare myocardium (arrow). The uncovered region corresponds
to an area of thin myocardium (arrowhead, compare to the epicardially covered area, double arrowhead). Bar, 66 m. (C–E) Confocal images
of a pouch-like structure in the ventral right ventricular wall of a stage H/H26 ablated embryo. In (C), the myocardium (MF20-positive)
appears in green. RALDH2 expression, in red, appears in the epicardial epithelium (EP) and subepicardial mesenchyme. Bar, 66 m. In (D),
a double RALDH2 (red) and vimentin (green) staining of this pouch is presented. The lumen of the pouch (asterisk) is covered by
vimentin-positive endothelium (arrowheads). The endocardium (double arrowheads) is also vimentin-positive. The outer (epicardial) side
of the structure is covered by a thick layer of RALDH2-positive subepicardial mesenchyme (arrows). Bar, 33 m. (E) A double cytokeratin
(red) and vimentin (green) staining of the same embryo and area shown in (C) and (D). The lumen of the pouch is covered by
vimentin-positive endothelial tissue and associated mesenchyme (arrowheads). The epicardial side consists of a cytokeratin-expressing belt
of tissue (arrows); note that most of the subepicardial tissue coexpresses cytokeratin and vimentin (labeled in yellow). Some of these
double-stained mesenchymal cells immigrate into the depths of the pouch (double arrowheads). Bar, 33 m. In (F), a section of a pouch in
an older ablated chick embryo is shown (H/H34). The wall of the pouch is now more compact and defined; its external side is indicated by
arrows. Layers of caldesmon-positive (red) cells (arrowheads) are seen in close vicinity of the inner endocardial lining of the pouch (asterisk).
Bar, 66 m. The sections in (G) and (H) show the expression of SMA (arrows) in the endocardial AV cushion of a control (G) and
experimental (H) embryo at stage H/H31. Bars, 90 m. A, atrium; CM, cushion mesenchyme; EP, epicardium; Li, liver; MYO, myocardium;
SE, subepicardium; SV, sinus venosus; V, ventricle; VM, ventricular myocardium.
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ocyte differentiation was also indicated in studies where
epicardial cells were cocultured with isolated cardiomyo-
cytes (Eid et al., 1992). In these studies, it was shown that
when cultured in the presence of epicardial cells, isolated
ventricular myocytes express more ventricular myosin
heavy chain and form myofibrillar arrays that are more
organized than those in cells that were not cultured in the
presence of epicardial cells. It is important to realize that
these observations were made years before it became clear
that the epicardium gives rise to a subpopulation of highly
invasive cells that populate several structures of the devel-
oping heart, including the ventricular myocardial wall
(Dettman et al., 1998; Gittenberger-de Groot et al., 1998;
Ma¨nner, 1999).
EPDCs, Coronary Vasculature, and Pouch-Like
Structures
Proepicardial block or ablation does not prevent the
myocardium from becoming covered by “epicardial-like”
tissue. In the proepicardial block, this tissue might derive
from the original proepicardium as a result of late proepi-
cardial attachment to myocardium (usually heterotopic
resulting from the experimental manipulations). This tis-
sue has been described as a secondary sinu-ventricular
mesocardium by Ma¨nner (1993). In the ablation experi-
ments, the epicardial-like tissue likely derives from coelo-
mic epithelium in the vicinity of the original proepicar-
dium. All the mesothelium of the region is highly
proliferative as shown by BrdU incorporation (data not
shown). Removal of the main mass of proepicardial tissue
does not seem to prevent the growth of a new proepicardial-
like structure. It is important to clarify that the tissue in
both the normal proepicardia and compensatory structures
found after ablation are of mesothelial nature, i.e., deriva-
tives of the coelomic epithelium and not of the sinus
venosus myocardium or of the hepatocytes of the liver
primordium.
The “epicardial-like” tissue in proepicardial block and
ablation locally produces “EPDCs” through EMT, albeit
that the overall number of these cells in the subepicardium
is considerably lower than that seen in normal hearts. In
addition, in our experimental embryos, coronary develop-
ment was found to be perturbed. These abnormalities
included widening of coronaries and ectopic location of
larger vessels. We did not perform a detailed study of
coronary development in normal and epicardially perturbed
hearts in the context of this paper. However, this aspect is
the focus of a forthcoming study.
The alterations of coronary vessel formation was accom-
panied by the formation of pouch-like structures that ap-
pear to be ectopic endocardial sinusoids. Our data suggest
that direct contact between endocardium and subepicardial
tissues cause massive differentiation of EPDCs into the
smooth muscle cell lineage, which leads to the formation of
a “media-like” cell layer. This is in accordance with the
role that the endothelium plays in recruitment and differ-
entiation of perivascular/smooth muscle cells (Hungerford
and Little, 1999), a process that is apparently regulated by
PDGF-BB secretion (Carmeliet, 2001).
The pouch-like structures resemble the conotruncal ab-
normalities found in the connexin43 k.o. mouse (Reaume et
al., 1995; reviewed in Lo, 1999). Interestingly, recent obser-
vations suggest that this particular phenotype might (par-
tially) be caused by an alteration in epicardial migration in
the conoventricular region of the heart (Li et al., 2002). In
this respect, it is important to note that there is a growing
body of evidence that outflow tract epicardium might be
partly derived from coelomic epithelium at the anterior
pole of the heart (Pe´rez-Pomares et al., 2001).
EPDCs in the Endocardial Cushions. A Link to the
Coronary Smooth Muscle Cell Lineage
EPDCs in the AV endocardial cushions express the
smooth muscle cell-related markers caldesmon and alpha
smooth-muscle actin (SMA). Both markers are also de-
tected in EPDCs from the subepicardium, where EPDCs
contribute to the formation of the media of the developing
coronary arteries. Caldesmon expression is not abundant in
the myocardial layers, though it can be found in some
scattered cells in close relation to the developing coronary
endothelium. It appears that the expression of caldesmon in
EPDCs is related to the proximity of these cells to the
endothelium. Although the endocardial cushions are
known to lack smooth muscle cells, a population of valvu-
lar interstitial cells, which present an intermediate pheno-
type between fibroblasts and vascular muscle cells, has
been described in mammals (Filip et al., 1986). The embry-
onic origin and role of these cells, which are coupled and
innervated by motor nerve endings, are not clear. Here, we
present data that at least a subset of these progenitors of
these valvular interstitial cells could be EPDCs that have
invaded the endocardial cushions. These valvular EPDCs
seem to have (at least partially) gone through the same
differentiation events as the EPDCs that form the coronary
smooth muscle cells (Mikawa and Gourdie, 1996; Lander-
holm et al., 1999; Vrancken Peeters et al., 1999; Lu et al.,
2001). Given the abnormalities observed in the experimen-
tal embryos, one can speculate that valvular EPDCs form an
important role in the development of these structures.
However, when we compared smooth muscle cell marker
expression in valvuloseptal tissue of control and experi-
mental specimens (Figs. 7G and 7H), we did not find a
significant difference in expression in comparable regions.
In this respect, it is noteworthy that it is well documented
that SMA is also expressed in cushion mesenchymal cells
after undergoing endocardial-to-mesenchymal transforma-
tion (Nakajima et al., 1997, 1998; Ramsdell and Markwald,
1997). Hence, it is likely that the expression of smooth
muscle cell markers in cushion mesenchymal cells is a
result of both differentiation events, and that the SMA/
caldesmon-positive cells that we detect immunohisto-
chemically in sections can be endocardially as well as
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epicardially derived. The fact that we did not observe a
difference in the expression of smooth muscle cell markers
in the endocardial cushion tissues of control vs proepicar-
dial ablated embryos leads to a number of hypothetical
mechanisms. First, the migratory behavior of EPDCs in
proepicardial ablations (hence tissue derived from the com-
pensatory tissue) could be altered compared with that of
EPDCs (derived from the proepicardium) in control hearts.
In this scenario, it is possible that subsets of EPDCs do
arrive in the cushions but not in the same time frame
and/or number. It is also possible that the EPDCs in the
cushions are involved in controlling endocardial-to-
mesenchymal transformation similar to the proposed
mechanism for the regulation of developing endothelium
by perivascular cells/pericytes through the tie2/Ang1 sys-
tem (Suri et al., 1996; Maisonpierre et al., 1997). If this is
FIG. 8. EPDCs characterization in proepicardial blocked embryos. (A, C) Images of a control chick embryo at stage H/H27. (B, D) A H/H27
proepicardially blocked chick embryo. The detail of the right ventricular myocardium in (A) shows WT1 expression (red nuclei) in the
epicardium and EPDCs. The image shows a well-developed epicardium and an abundant subepicardium with WT1-positive cells. EPDCs
in the myocardium are indicated with arrowheads. Bar, 45 m. In (B), a picture of the same region at the same magnification in an ablated
embryo is presented. The WT1 expression (red nuclei) is normal in the pericardium (PE, positive control) as compared with the same tissue
in (A). However, the amount of WT1-positive cells in the delayed epicardium is low (arrowheads, compare with A) and WT1-reactive EPDCs
are almost absent from the myocardial layers. Note that the thickness of the compact myocardium of the area is at least one-half of that
of the normal myocardium (double-headed arrows in A and B). Bar, 45 m. In (C), a confocal image of a RALDH2-stained H/H27 chick
embryo is shown. The red cytoplasmic labeling is found in the epicardium (EP) as well as in some mesenchymal cells in the myocardial
layers (arrowheads). Bar, 90 m. In (D), a detail of an H/H27-blocked embryo is presented. The RALDH2 expression in the epicardium is
more heterogeneous, with areas of very weak expression. RALDH2-positive cells are not found in the myocardium. Bar, 90 m. BW, body
wall; EP, epicardium; MYO, myocardium; PE, pericardium; SE, subepicardium.
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the case, a change in the number of EPDCs in the cushions,
or the temporal window in which the EPDC invade the
cushions, would not only alter the EPDC-related SMA
expression, but would at the same time also perturb the
endocardially derived SMA-positive population.
CONCLUSION
We conclude that all or at least most of the subepicardial
mesenchymal cells are EPDCs as suggested by their expres-
sion of WT1 and RALDH2 in an early stage. These markers
seem to disappear from most EPDCs as they differentiate
into other cell lineages, such as fibroblasts, vascular smooth
muscle, and endothelial cells (Dettman et al., 1998;
Gittenberger-de Groot et al., 1998; Pe´rez-Pomares et al.,
1998). The nondifferentiated cells, which continue to ex-
press WT1 and RALDH2, invade the ventricular myocar-
dium. It is tempting to speculate that EPDC–RALDH2-
mediated synthesis of RA is an effective way to locally
release RA within the developing ventricular layers. We
suggest that the developmental process that leads to ven-
tricular myocardium compaction is dependent on the inva-
sion by retinoid-producing EPDCs. It is plausible that the
first wave of RA-producing EPDCs invading the ventricular
myocardium plays a role in the induction of downstream
molecules involved in myocardial maturation. One of these
downstream targets could be IGF-2 (Vincent et al., 1996), a
mitogen which is involved in the thickening of the myo-
cardium (Liu et al., 1996). The role played by WT1 in the
development of the myocardial wall might be to maintain
the EPDCs in an undifferentiated, RA-producing state. The
inactivation of this gene would cause premature differen-
tiation of the EPDCs, resulting in the downregulation of RA
production. This hypothesis is supported by the “thin
myocardium” syndrome reported for the WT1-k.o. and
RXR-alpha-k.o. mice.
EPDCs were never observed in the myocardial walls of
atria and OFT. In itself this is not surprising as the epicar-
dial epithelia of atria and OFT do not undergo EMT to
generate a population of subepicardial EPDCs (Pe´rez-
Pomares et al., 1997). In line with the above hypothesis
about the role of EPDCs in myocardial development, the
myocardial walls of the atria and OFT do not thicken over
time but instead remain thin. It is possible that the absence
of EPDCs in atria and OFT is a result of differences in
intrinsic properties between the atrial/OFT myocardium
and the ventricular myocardium. It is also possible, but less
likely, that these phenomena are resulting from intrinsic
differences in the epicardial epithelium covering these
segments.
The presence of numerous EPDCs in the AV valves,
combined with the observation that proepicardial block/
ablations impair AV valve development, suggest an impor-
tant role for EPDCs in valvuloseptal morphogenesis. Given
the fact that the only other tissue types in the AV valves are
endocardial and endocardially derived mesenchyme, one
has to assume that proper interaction between EPDCs and
these cells is imperative for correct valve formation. The
developmental mechanisms involved are yet to be eluci-
dated but could involve regulation of endocardial EMT,
regulation of cell division and cell death (cf. Lakkis and
Epstein, 1998), regulation of cell migration, and regulation
of extracellular matrix production.
In summary, we suggest that EPDCs not only materially
contribute to the different tissues of the heart (i.e., coronary
endothelium/smooth muscle, interstitial fibroblasts, and
cushion mesenchyme), but that they also have a critical
function in the differentiation of the ventricular myocar-
dium and the AV valves.
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